English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Conference Paper

Causal therapy of prion and Parkinson's disease with novel inhibitors of protein aggregation.

MPS-Authors
/persons/resource/persons45923

Ryazanov,  S.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15438

Leonov,  A.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons15147

Griesinger,  C.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Kretzschmar, H., Wagner, J., Ryazanov, S., Leonov, A., Levin, J., Shi, S., et al. (2011). Causal therapy of prion and Parkinson's disease with novel inhibitors of protein aggregation. Journal of Neuropathology and Experimental Neurology, 70(6), 505-505.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0011-F3B2-F
Abstract
There is no abstract available